Christian Werno
Research group leader “Preclinical Therapy Models” at Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Division of Personalized Tumor Therapy
Christian Werno is a biologist who got his PhD at Goethe University Frankfurt am Main. Then he worked as a postdoctoral fellow at Fraunhofer ITEM Regensburg Division of Personalized Tumor Therapy.
Since 2015 he is leader of the “Preclinical Therapy Models” research group at Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Division of Personalized Tumor Therapy. His group has focused on development and functional testing of CTC-derived in vivo and in vitro models from metastatic cancer patients.
Title: Clinical applications of liquid biopsies
We have generated CTC-derived in vivo and in vitro models from metastatic cancer patients. We characterized these models and performed drug screens. By linking molecular data from single CTC with functional data from CTC-derived preclinical models we intend to improve liquid biopsy directed personalized treatment strategies for metastatic patients in future.